Compound Profile

Mangiferin Aglycone

Xanthone aglycone metabolite of mangiferin produced by gut microbiota after oral ingestion.

Use extra caution Mostly preclinical/extract derived; concentrated Garcinia/mangosteen extracts may affect bleeding or liver risk depending product. Details

Last reviewed: Report a correctionProfile-wide ·C Limited
Mangiferin Aglycone monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Mostly preclinical/extract-derived; concentrated Garcinia/mangosteen extracts may affect bleeding or liver risk depending product.
Profile context
NF-κB, antioxidant response, apoptosis signaling
Next steps

Continue reading

Quick stats

Evidence level
Limited evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
NF κB, Antioxidant Response, Apoptosis Signaling
Avoid / review if
Liver

Botanical Context

Source botanicals and comparison guides related to Mangiferin Aglycone.

Safety

Safety & Cautions

Mostly preclinical/extract derived; concentrated Garcinia/mangosteen extracts may affect bleeding or liver risk depending product.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.

Evidence Summary

Profile-wide ·C Limited

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedImmune Signaling Modulation · AMPK Pathway Activation · Metabolic Regulation

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableMostly preclinical/extract derived; concentrated Garcinia/mangosteen extracts may affect bleeding or liver risk depending product.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Limited evidence

Mangiferin Aglycone has a limited evidence rating.

AdaptogenStress & MoodLongevity
Effects
4
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials

How Mangiferin Aglycone Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Mangiferin Aglycone Works

How Mangiferin Aglycone WorksMangiferin Aglycone acts on biological target pathways via anti inflammatory, leading to nf κb.Mangiferin AglyconeBiological TargetBiological pathwayAnti InflammatoryNf κBObservable outcomeAntioxidantParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
standardized extract capsule
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Immune Signaling Modulation
  • AMPK Pathway Activation
  • Metabolic Regulation
  • Nrf2/ARE Pathway Activation
  • AMPK Signaling
  • Mitochondrial Support

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Mangiferin Aglycone evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?